|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0410 USD | +13.89% |
|
+2.50% | +57.69% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 9.54M | - | - | - | - | - |
| 63.43B | |||||
| 55.14B | |||||
| 41.58B | |||||
| 37.99B | - | ||||
| 29.47B |
Select your edition
All financial news and data tailored to specific country editions
